Partner Content Partner Content Exclusive Pharma Microbiology interview with Maria Jose Lope... Exclusive Microbiology interview with Maria Barragan
Partner Content Partner Content Exclusive Interview Matts Ramstorp Chair for SMi's Next Gene... Exclusive Interview Matts Ramstorp Chair Cleanroom Conf
News Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
